Perbedaan Kalbe Farma Tbk dan Trimegah Karya Pratama Tbk.: Kalbe Farma Tbk diperdagangkan di Rp720 (kapitalisasi pasar 33 T, volume 24 jam 98,44 jt), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp139 (kapitalisasi pasar 272,02 M, volume 24 jam 55,79 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 121,3× kapitalisasi pasar Trimegah Karya Pratama Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (98,44 jt vs 55,79 jt). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 33 T | 272,02 M |
Volume | 98,44 jt | 55,79 jt |
Lot | 984,38 rb | 557,94 rb |
Perputaran | 70,64 M | 7,75 M |
Harga Rata-rata | 717,58 | 138,88 |
Nilai Transaksi | 70,64 M | 7,75 M |
Harga Ekuilibrium Indikatif | 720 | 139 |
Volume Ekuilibrium Indikatif | 43,62 rb | 6,83 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →